INTRODUCTION
Isovaleric acidemia, an inborn error of leucine metabolism, is characterized clinically by bouts of recurrent ketoacidosis and coma which are accompanied by a peculiar offensive odor described like "sweaty feet" (1, 2) . The severe acidotic attacks are frequently observed during the newborn period (2, 3) and often result in death (3, 4) . At least 19 cases have been reported (5) . The major biochemical features of this disease are continuous excretion of large amounts of isovalerylglycine in urine (6) and episodic accumulation of serum isovaleric acid (1) and urinary P-hydroxyisovaleric acid (7) during the periods of acute ketoacidosis. From the identification of these abnormal metabolites and also from the inability of patient's leukocytes to oxidize [1-14C] isovaleric acid, it was assumed that isovaleric acidemia is due to a block in leucine metabolism at the step of isovaleryl coenzyme A (CoA) 1 dehydrogenation (1, 6) . The altered metabolism of leucine in patients with this disease is illustrated in Fig. 1 . Further biochemical studies on the nature of the enzyme defect have been hampered by a difficulty in the direct assay of isovaleryl CoA dehydrogenase activity in crude tissue preparations such as homogenates of liver and leukocytes. These difficulties were due to strong nonspecific reduction of 1Abbreviations used in this paper: CoA, coenzyme A; FAD, flavin adenine dinucleoside; MCPA, methylenecyclopropyl acetic acid; MSUD, maple syrup urine disease. artificial electron acceptors which were used in the dehydrogenase assay.' It has been subsequently shown by identification of accumulated products that hypoglycin A and its metabolites specifically inhibit isovaleryl CoA dehydrogenase in vitro (8) and that isovaleric acidemia is inducible in experimental animals by a single dose of hypoglycin A (9, 10). Hypoglycin A is a toxic amino acid with an unusual chemical structure, L-a-amino-methylenecyclopropylpropionic acid (Fig. 2) . It is extracted from a local Jamaican fruit, ackee, and has been identified as the causative agent of the vomiting sickness of Jamaica (11) .
The present studies were undertaken to study further the nature of the defect in leucine metabolism in isovaleric acidemia using tissue culture fibroblasts. This was done by measuring radioactive C02 production and labeled isovaleric acid after incubation of the cells with [1-14C] (Fig. 1) . Thus, the use of these two substrates makes it possible to distinguish the defect of oxidative decarboxylation from those localized at the later stages by measurement of 14CO production.
If the pathway is blocked at stages distal to oxidative decarboxylation, accumulation of radioactive intermediates may be detected from the assay medium with [2-14C] The analysis of radioactive isovalerylglycine was also done by radio-gas-liquid chromatographic. The preparation of samples for the analyses was done by the method previously described (8) .
D 
Due to the unexpected observation of a low oxidation of [1-14C] leucine in isovaleric acidemia cells, the radiopurity of [1-"C]leucine used was checked in our laboratory. More than 98% of the radioactivity migrated with leucine on high voltage paper electrophoresis using 6% formic acid as a buffer. 99% of the radioactivity was lost after ninhydrin treatment, indicating that the 1'C is, in fact, located at carbon 1 of leucine (14) . Thus, we confirmed that the [1-"C] leucine was radiochemically pure.
The ability to oxidize both substrates by cells from an obligate heterozygote for isovaleric acidemia was lower than the lowest control and was about 40% of the mean control value (Table I) . The ability to oxidize [1-14C] leucine by cells from the parents of a MSUD patient was about 20% of the mean control value. Oxidation of [2-"C]leucine by these cells was not measured.
Six cell lines cultured from normal amniotic fluids actively oxidized both substrates. They produced "CG2 in the amounts of 1074±91 SD and 227+77 SD pmol/106 cells/h from [1-14C] and [2-14C]leucine, respectively. These were about a half of the mean value for normal skin fibroblasts.
Inhibition by MCPA of [1-14C] normal cells by 94-97%. It also inhibited "4C02 production from [1-14C] leucine, but the inhibition was about 55-65% as shown in Table II . The pattern of inhibition of leucine oxidation in normal cells in the presence of MCPA is similar to the situation observed with isovaleric acidemia cells (Table I) .
Analyses of radioactive isovaleric acid and isovalerylglycine in assay media wxith [2-14C] leucine as substrate. The inability of MSUD cells to oxidize either [1-"C] or [2-14C] leucine is consistent with the enzyme defect of MSUD being located at the oxidative decarboxylation step (Fig. 1) . However, the pattern of decreased 14CO2 production from [2-14C]leucine seen in isovaleric acidemia cells may be explained by a metabolic block at any step after the oxidative decarboxylation. Therefore, after incubating cells with [2-14C] leucine, the assay medium was analyzed for accumulated radioactive intermediates to locate the metabolic block in isovaleric acidemia cells more specificially.
First, the assay medium was analyzed for radioactive organic acids including isovalerylglycine and P-methylcrotonylglycine. Glycine (3 mM) was added to the assay medium in this experiment since the addition of glycine greatly enhanced the isovalerylglycine formation from leucine by rat liver slices in the presence of a-ketomethylenecyclopropylpropionic acid (8, 10) . The addition of glycine did not alter "CO2 production from [2- In the assay media with normal cells there was a small, ambiguous radioactive peak which appeared in the region of isovaleric acid (Fig. 5, right) . In contrast, a high radioactive isovaleric acid peak was detected in the assay media with isovaleric acidemia cells (Fig. 5,   left ) and also in that with normal cells in the presence of MCPA (Fig. 6 ). The amount of radioactivity was calculated as a ratio of the area of the radioactive peak over that of the peak by mass detection since the same amount of nonlabeled isovaleric acid was added as a carrier to each medium after incubation. The amount of radioactive isovaleric acid was at least significantly higher in the assay media with isovaleric acidemia cells than in the control cells. The amount of radioactive isovaleric acid was also high in the assay medium when normal cells were incubated with MCPA (Table III) . It was very low in an assay medium with MSUD cells. No radioactive peak was detected in the region of B-methylcrotonic acid in the assay media with isovaleric acidemia cells nor with normal cells in the presence of MCPA.
Inhibition of "COs production from [U-`C]leucine by isovaleric acid. One of the possible reasons for the partial depression of [1-2C] leucine oxidation in isovaleric acidemia cells is that oxidative decarboxylation of a-ketoisocaproic acid is secondarily inhibited by the accumulated product, isovalerate. Therefore, the effect of isovaleric acid on HCO2 production from [1-"C]leucine by normal fibroblasts was tested. Isovaleric acid inhibited the activity to 67% at 5 mM and to 32% at 10 mM (Table IV) .
Effect of FAD on leucine oxidation by cultured fibro- by isovaleric acidemia cells was not augmented to any degree by the addition of FAD in either fashion (Table  V) . Numbers of cell lines tested are presented in parentheses in cell line column. * The amount of radioactive isovaleric acid is expressed as the ratio of area of radioactive peak per peak area by mass detection. The radioactivity was detected at a sensitivity of 300 cpm full scale. Mass detection was done with a hydrogen flame detector at a sensitivity of 10' ampere full scale. l mg of carrier isovaleric acid was added to all samples.
10.7 mM. ficient cells must be tested in the future. An abnormality in leucine metabolism similar to that seen in isovaleric acidemia cells was induced in normal fibroblasts by the addition of MCPA, a toxic metabolite of hypoglycin A. The findings indicate that hypoglycin A and its metabolites inhibit isovaleryl CoA dehydrogenase as has been shown in rats (8, 10) , and that acquired isovaleric acidemia may be observed in patients with the Jamaican vomiting sickness (9, 10). The experiments were done in duplicate using microvessels.
* Cells were grown in the incubation medium with FAD for 5 days before harvesting. Oxidation of other substrates, [1,4-14C] succinate, and [1-14C]valine, were studied in an isovaleric acidemia cell line as well as in two controls. The rate of succinate oxidation by isovaleric acidemia cells was in the same range as that of the controls. Therefore, general metabolic activity of the isovaleric acidemia cell line appears to be normal. In contrast, '4COs production from [1-14C]- valine by isovaleric acidemia cells was about 50% of a control. Whether this is due to a cross inhibition of a-ketoisovalerate decarboxylation by accumulated metabolites remains to be determined.
Radioactive carbon dioxide from [2-"C] leucine by cells from an obligate heterozygote for isovaleric acidemia was about 40% of the mean control value. Intermediate values of 1'COs production from [1-'C]leucine were likewise observed in two cell lines heterozygous for MSUD as has been previously reported (18, 19) . Langenbeck et al. commented that due to a large variation of data, diagnosis of the heterozygous state of MSUD was not possible when cultured fibroblasts were incubated using branched-chain a-keto acids as substrates (20) . The possibility of using these methods with [14C]-leucine as substrate for the detection of heterozygotes of these inborn metabolic diseases must be determined by much larger numbers of assays on heterozygous cells and controls. Even with much more data, it is likely that there will be considerable overlap of heterozygous and control values using an assay that measures C02 production.
Vitamin responsiveness has never been tested clinically in cases of isovaleric acidemia because the biochemical characteristics of isovaleryl CoA dehydrogenase are currently unknown. However, the type of substrate and the nature of the reaction are analogous to those of green acyl CoA dehydrogenase, a flavin enzyme (15, 21) . Therefore, we examined the effect of FAD on leucine oxidation by isovaleric acidemia cells. Oxidation of neither [1-14C] nor [2-`4C]leucine was restored by the addition of FAD either in culture medium or assay medium.
Investigation on the accumulated abnormal metabolites in the assay medium resulted in the identification of free isovaleric acid rather than isovalerylglycine as the product from [2-14C]leucine in isovaleric acidemia fibroblasts, and also in normal fibroblasts in the presence of MCPA. This was in contrast to the previous findings that the major abnormal metabolite from leucine in vivo in patients with isovaleric acidemia (6) and also in hypoglycin A treated rats (13) was isovalerylglycine, and that the product from [2JYC]leucine by rat liver slices in vitro in the presence of a-ketomethylenecyclopropylpropionic acid was also isovalerylglycine (8) . These observations would be explained if cultured fibroblasts lack glycine-N-acylase. This enzyme is known to be present in liver and kidney (22) but its activity has not been tested in fibroblasts.
The procedures described in this paper may be utilized clinically for prenatal diagnosis of isovaleric acidemia. A preliminary report on this subject, has been published (12) . The ability of normal amniotic fluid cells to oxidize both substrates were about 50% of normal skin fibroblasts. One of the cell lines that was used for the study of MCPA inhibition was derived from amniotic fluid. Therefore, it is quite likely that amniotic fluid cells from an affected fetus would show the same defect of leucine metabolism as that detected in skin fibroblasts from isovaleric acidemia patients.
